Albireo Pharma, Inc. announced the appointment of Martha J. (Muffy) Carter as Chief Regulatory Officer. In this role, Ms. Carter will oversee all regulatory affairs for Albireo worldwide. Most recently, Ms. Carter was Chief Regulatory Officer and Senior Vice President of Aegerion Pharmaceuticals, where she established global regulatory and quality functions and played a key role in bringing JUXTAPID®/LOJUXTA® (lomitapide) for the treatment of homozygous familial hypercholesterolemia to market. Prior to Aegerion, Ms. Carter served as Senior Vice President and Chief Regulatory Officer at Proteon Therapeutics and Senior Vice President, Regulatory Affairs at Trine Pharmaceuticals.